These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20864412)

  • 1. Single nucleotide polymorphisms in the anti-Müllerian hormone signalling pathway do not determine high or low response to ovarian stimulation.
    Hanevik HI; Hilmarsen HT; Skjelbred CF; Tanbo T; Kahn JA
    Reprod Biomed Online; 2010 Nov; 21(5):616-23. PubMed ID: 20864412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single nucleotide polymorphism in BMP15 is associated with high response to ovarian stimulation.
    Hanevik HI; Hilmarsen HT; Skjelbred CF; Tanbo T; Kahn JA
    Reprod Biomed Online; 2011 Jul; 23(1):97-104. PubMed ID: 21565556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
    Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
    Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment.
    Andersen AN; Witjes H; Gordon K; Mannaerts B;
    Hum Reprod; 2011 Dec; 26(12):3413-23. PubMed ID: 21954280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].
    Grzegorczyk-Martin V; Khrouf M; Bringer-Deutsch S; Mayenga JM; Kulski O; Cohen-Bacrie P; Benaim JL; Belaisch-Allart J
    Gynecol Obstet Fertil; 2012; 40(7-8):411-8. PubMed ID: 22521986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
    Muttukrishna S; Suharjono H; McGarrigle H; Sathanandan M
    BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
    Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
    BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve.
    Kwee J; Schats R; McDonnell J; Themmen A; de Jong F; Lambalk C
    Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome.
    Kevenaar ME; Themmen AP; van Kerkwijk AJ; Valkenburg O; Uitterlinden AG; de Jong FH; Laven JS; Visser JA
    Hum Reprod; 2009 Jan; 24(1):241-9. PubMed ID: 18854405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of FSHR variants and antimüllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation.
    Binder H; Strick R; Zaherdoust O; Dittrich R; Hamori M; Beckmann MW; Oppelt PG
    Fertil Steril; 2012 May; 97(5):1169-75.e1. PubMed ID: 22401810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.
    Cupisti S; Dittrich R; Mueller A; Strick R; Stiegler E; Binder H; Beckmann MW; Strissel P
    Eur J Med Res; 2007 Dec; 12(12):604-8. PubMed ID: 18024272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single nucleotide polymorphisms in the Anti-Müllerian hormone (AMH Ile(49)Ser) and Anti-Müllerian hormone type II receptor (AMHRII -482 A>G) as genetic markers in assisted reproduction technology.
    Karagiorga I; Partsinevelos GA; Mavrogianni D; Anagnostou E; Zervomanolakis I; Kallianidis K; Drakakis P; Loutradis D
    J Assist Reprod Genet; 2015 Mar; 32(3):357-67. PubMed ID: 25542251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of gene polymorphisms in the anti-Müllerian hormone signalling pathway with ovarian function: a systematic review and meta-analysis.
    Cheng R; Xiong W; Luo X; Ma Y; Nie Y; Qiao X; Chen H; Hu Y; Xu L
    Reprod Biomed Online; 2019 Sep; 39(3):513-521. PubMed ID: 31253588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF.
    Yates AP; Rustamov O; Roberts SA; Lim HY; Pemberton PW; Smith A; Nardo LG
    Hum Reprod; 2011 Sep; 26(9):2353-62. PubMed ID: 21672928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can anti-Müllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation?
    Fleming R; Broekmans F; Calhaz-Jorge C; Dracea L; Alexander H; Nyboe Andersen A; Blockeel C; Jenkins J; Lunenfeld B; Platteau P; Smitz J; de Ziegler D
    Reprod Biomed Online; 2013 May; 26(5):431-9. PubMed ID: 23507133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability.
    Rustamov O; Smith A; Roberts SA; Yates AP; Fitzgerald C; Krishnan M; Nardo LG; Pemberton PW
    Hum Reprod; 2012 Oct; 27(10):3085-91. PubMed ID: 22777530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.